Comerica Bank grew its position in Cooper Companies Inc (NYSE:COO) by 10.0% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 14,902 shares of the medical device company’s stock after purchasing an additional 1,349 shares during the period. Comerica Bank’s holdings in Cooper Companies were worth $3,566,000 at the end of the most recent quarter.
Other hedge funds have also recently made changes to their positions in the company. Advisory Services Network LLC increased its holdings in shares of Cooper Companies by 30.6% in the second quarter. Advisory Services Network LLC now owns 457 shares of the medical device company’s stock valued at $109,000 after purchasing an additional 107 shares during the period. Canada Pension Plan Investment Board acquired a new position in shares of Cooper Companies in the third quarter valued at about $163,000. Ballentine Partners LLC acquired a new position in shares of Cooper Companies in the third quarter valued at about $223,000. CAPROCK Group Inc. acquired a new position in shares of Cooper Companies in the fourth quarter valued at about $222,000. Finally, FNY Managed Accounts LLC acquired a new position in shares of Cooper Companies in the fourth quarter valued at about $217,000. 96.27% of the stock is currently owned by institutional investors and hedge funds.
A number of brokerages have recently weighed in on COO. Cleveland Research lowered Cooper Companies from a “buy” rating to a “hold” rating in a report on Friday, February 9th. Raymond James Financial reissued a “buy” rating and issued a $265.00 price objective on shares of Cooper Companies in a report on Monday, December 4th. Zacks Investment Research raised Cooper Companies from a “hold” rating to a “buy” rating and set a $257.00 price objective on the stock in a report on Tuesday, November 14th. Oppenheimer set a $250.00 price objective on Cooper Companies and gave the company a “hold” rating in a report on Friday, December 8th. Finally, Stifel Nicolaus reissued a “buy” rating and issued a $265.00 price objective (down from $275.00) on shares of Cooper Companies in a report on Friday, December 8th. Eight research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. The company has a consensus rating of “Hold” and a consensus price target of $259.70.
Shares of Cooper Companies Inc (NYSE COO) opened at $232.47 on Friday. Cooper Companies Inc has a one year low of $189.41 and a one year high of $256.39. The company has a quick ratio of 1.26, a current ratio of 2.41 and a debt-to-equity ratio of 0.36. The company has a market capitalization of $11,395.91, a PE ratio of 23.92, a PEG ratio of 1.87 and a beta of 0.57.
Cooper Companies (NYSE:COO) last issued its earnings results on Thursday, December 7th. The medical device company reported $2.65 EPS for the quarter, topping analysts’ consensus estimates of $2.64 by $0.01. Cooper Companies had a return on equity of 16.02% and a net margin of 17.43%. The firm had revenue of $561.50 million for the quarter, compared to the consensus estimate of $558.86 million. During the same quarter in the prior year, the business earned $2.28 earnings per share. The company’s revenue was up 8.3% compared to the same quarter last year. research analysts expect that Cooper Companies Inc will post 11.55 EPS for the current fiscal year.
The business also recently announced a semiannual dividend, which was paid on Friday, February 9th. Stockholders of record on Tuesday, January 23rd were paid a $0.03 dividend. The ex-dividend date was Monday, January 22nd. This represents a dividend yield of 0.03%. Cooper Companies’s payout ratio is 0.80%.
In other news, Director Allan E. Rubenstein sold 6,450 shares of the company’s stock in a transaction dated Friday, January 12th. The stock was sold at an average price of $228.79, for a total value of $1,475,695.50. Following the sale, the director now owns 8,628 shares in the company, valued at $1,974,000.12. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Gary S. Petersmeyer sold 785 shares of the stock in a transaction that occurred on Friday, December 15th. The stock was sold at an average price of $229.06, for a total value of $179,812.10. The disclosure for this sale can be found here. Insiders sold 54,385 shares of company stock worth $12,289,463 in the last 90 days. Company insiders own 1.60% of the company’s stock.
About Cooper Companies
The Cooper Companies, Inc is a global medical device company. The Company operates through two business units: CooperVision, Inc and CooperSurgical, Inc CooperVision offers soft contact lenses for the vision correction market. CooperVision develops, manufactures and markets a range of single-use, two-week and monthly contact lenses.
Want to see what other hedge funds are holding COO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cooper Companies Inc (NYSE:COO).
Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.